// App-Quantinova.ai

e22022 : Development of a circulating tumor cell assay for use in selecting patients for a novel antibody-drug conjugate therapy*.

Researchers

Presenter

  • Xiaolei Qiu

Principal Investigators

  • Hilda Beas

  • Madeleine Matias

  • Michael Pugia

  • Omar Perez

  • Steven Robert Pirie-Shepherd

  • Harwinder Sidhu

  • Albert Chmura

  • Rong Jiang

  • Sebastian Kronmueller

  • Julia Philip

  • Karen Marfurt

  • Arejas Uzgiris

  • Monalisa Ray

  • Sunil Pandit

Medical Centers

  • Pfizer Inc, San Diego, CA

  • Pfizer, San Diego, CASiemens Clinical Laboratory, Berkeley, CASiemens Healthcare Diagnostics, Elkhart, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Apparent diffusion coefficient

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved